ArticleNanoscale advances2024
The impact of different flexible substrates on the photothermal reduction quality of graphene oxide.
Article in Nanoscale advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, we demonstrate the impact of the photothermal reduction quality of graphene oxide (GO), which is affected by the material composition, roughness, and thermal properties of the membrane substrates. We show high efficiency reduced graphene oxide (rGO) conversion by applying a 405 nm pulsed laser in ambient conditions onto different flexible substrates. Three filter membranes, such as nylon, cellulose acetate, and nitrocellulose, are used as rGO thin film substrates, achieving sheet resistance of 51 ± 2, 58 ± 3, and 620 ± 40 Ω sq
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.